Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 51Neoplasms 19Pain 15Peripheral Nervous System Diseases 10Hot Flashes 10Fatigue 10Prostatic Neoplasms 9Lung Neoplasms 9Multiple Myeloma 8Polycystic Ovary Syndrome 7Sleep Initiation and Maintenance Disorders 6Stomach Neoplasms 5Pancreatic Neoplasms 5Agnosia 5Insulin Resistance 4Depression 4Colorectal Neoplasms 4Cancer Pain 4Anxiety Disorders 4Xerostomia 3Nasopharyngeal Neoplasms 3Lymphoma 3Lymphedema 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vomiting 2Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2

Interventions

Metformin 7Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2maltodextrin 1bicalutamide 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Ultrasonography 1Topiramate 1Time 1Thioctic Acid 1Sodium Salicylate 1Sex Characteristics 1Physical Examination 1Phlebotomy 1Phenotype 1Ovidrel 1Magnesium 1Lactalbumin 1Inulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hyperandrogenism × Acupuncture Therapy × Clear all
NCT02647827 2024-10-09

PIAII

Karolinska Institutet

Phase 2 Recruiting
303 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡